Oligomerix, Inc., a privately held clinical stage company pioneering the development of oral, small molecule therapeutics ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

BOTHELL, Wash., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces it has received a Small Business Innovation Research (SBIR) Phase I ...

Today, educational software company Dynamoid announced the launch of the 10k Science immersive 3D experience collection. Among numerous updates to the main 10k Science VR application, including major ...

Money Moves is a recurring series where we chart the raises, grants, contracts, mergers and other funding news of tech companies across our regions. Have a tip? Email us at [email protected]. Life ...

RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...

WHITE RIVER JUNCTION, Vt., Nov. 18, 2025 /PRNewswire/ -- QUEL Imaging, a leader in biomedical optical characterization tools and services, and the Institut National d'Optique (INO), Canada's premier ...

FYR Bio ("FYR"), a leader in liquid-biopsy precision medicine for neuro-oncology, today announced a collaboration with NuvOx Therapeutics, Inc. ("NuvOx") supported by a two-year $1,976,897 ...

Decades of federally funded research at USF have led to a breakthrough device that uses gentle heat and electrical pulses to ...

By John Dudley, University Communications and MarketingA Tampa Bay-based innovation backed by more than three decades of ...

On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...